期刊文献+

PcDNA3.1-rhGM-CSF表达质粒的构建及其对K562细胞生长与分化的影响作用 被引量:2

Construction of the eukaryotic expressing vector of PcDNA3.1 rhGM-CSF and its effect on the proliferation and differentiation of K562 cells
暂未订购
导出
摘要 目的:观察GM-CSF对髓系白血病细胞(K562)生长、分化的影响作用。方法:采用PCR、T-A克隆及基因定向克隆技术,将rhGM-CSF基因插入PcDNA3.1(+)空载体中,构建了PcDNA3.1-rhGM-CSF真核表达载体。经限制性内切酶消化和DNA测序鉴定确认,转染人K562髓系白血病细胞、72小时后采用细胞形态学检测、MTT试验、免疫组化技术观察和分析PcD-NA3.1-rhGM-CSF在K562细胞中的表达及其影响该细胞生长与分化的作用。结果:①成功构建PcDNA3.1-rhGM-CSF真核细胞表达载体;②重组质粒PcDNA3.1-rhGM-CSF能在K562细胞中表达,并诱导K562细胞向单核细胞系、巨噬细胞系分化;③K562细胞增殖受到明显抑制。结论:成功构建了PcDNA3.1-rhGM-CSF真核细胞表达载体;转染K562细胞能向单核细胞系、巨噬细胞系分化。 Objective:To construct eukaryotic expressing vector of PcDNA3.1-rhGM-CSF and to investigate its effects of suppressing growth and inducing differentiation in K562 cells.Methods:The eukaryotic expressing vector PcDNA3.1-hGM-CSF was constructed by means of PCR and T-A clone techniques as well as directional cloning techniques.It was affirmed by the restriction map and DNA sequence analysis,and then transfected into K562 cells.It was observed that the target gene of the recombinant vector was expressed and exerted in K562 cells 72 h later,RT-PCR was used to affirm the expression of rhGM-CSF in K562 cells;Cell morphological,cell proliferation assay and immunohistochemistry were used to observe the effect of PcDNA3.1-rhGM-CSF on the growth and differentiation of K562 cells.Results:①The recombinant eukaryotic expressing vector PcDNA3.1-GM-CSF was constructed successfully;②Recombinant GM-CSF was expressed in the transfected K562 cells and the transfected K562 cells could differentiate into monocyte and macrophage cells;③ The proliferation of K562 cells was suppressed.Conclusion:The recombinant eukaryotic expression vector PcDNA3.1-rhGM-CSF was constructed successfully;Transfected K562 cell could differentiate into monocyte and macrophage cell.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2010年第6期494-497,502,共5页 Chinese Journal of Immunology
基金 四川省科技厅项目资助(2009SZ0260)
关键词 粒细胞-巨噬细胞集落刺激因子 重组表达载体 细胞分化 K562 GM-CSF The recombinant eukaryotic coexpression plasmid Cell differentiation K562
  • 相关文献

参考文献11

  • 1Bezbradica J S,Gordy L E,Stanic A K et al.Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny[J].Immunity,2006;25(3):487-497.
  • 2Chitta S,Santambrogio L,Stern L J.GM-CSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells[J].Immunol Lett,2008;15:116(1):41-54.
  • 3Coli (c) M,Jandri (c) D,Stoji (c)-Vukani (c) Z et al.Differentiation of human dendritic cells from monocytes in vitro using granulocyte-macrophage colony stimulating factor and low concentration of interleukin-4[J].Vojnosanit Pregl,2003;60(5):531-538.
  • 4Antignani A,Youle R J.The cytokine,granulocyte-macrophage colony-stimulating factor (GM-CSF),can deliver Bcl-XL as an extracellular fusion protein to protect cells from apoptosis and retain differentiation induction[J].Biol Chem,2007;282(15):11246-11254.
  • 5李迎春,卢香兰,刘云鹏,朱志图,杨德光,王萍萍.GM-CSF增强三氧化二砷诱导急性早幼粒细胞白血病细胞的分化作用[J].中华血液学杂志,2004,25(5):308-309. 被引量:2
  • 6Fernández-Varón E,Villamayor L.Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine[J].Vet J,2007;174(1):33-41.
  • 7Zijlmans H J,Fleuren G J,Baelde H J et al.Role of tumor-derived proinflammatory cytokines GM-CSF,TNF-alpha,and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma[J].Cancer,2007;109(3):556-565.
  • 8龚福生,郑秋红,郑天荣,谢云青,陈蓉明,汪相如.GM-CSF重组腺病毒转染外周血树突状细胞的研究[J].中华肿瘤防治杂志,2006,13(2):107-110. 被引量:3
  • 9Chang J W,Hsieh J J,Shen Y C.Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma[J].Melanoma Res,2009;19(5):309-315.
  • 10Zhang L,Chen J,Han C.A multicenter clinical trial of recombinant human GM-CSF hydrogel for the treatment of deep second-degree burns[J].Wound Repair Regen,2009;17(5):685-689.

二级参考文献34

  • 1郑秋红,龚福生,陈蓉明,谢云青,汪相如,郑天荣.GM-CSF基因重组腺病毒载体的构建及鉴定[J].肿瘤防治杂志,2005,12(4):257-260. 被引量:6
  • 2Niu C,Yan H,Yu T,et al.Studies on treatment of acute promyelocytic leukemia with arsenic trioxide:remission induction,follow-up,and molecular monitoring in 11 newly diagnosed and 47 relapsed promyelocytic leukemia patients.Blood,1999,84:3315-3324.
  • 3Chen GQ,Shi XG,Tang W,et al.Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL):Ⅰ.As2O3 exerts dose-dependent dual effects on APL cells.Blood,1997,89:3345-3353.
  • 4Muto A,Kizaki M,Kawamura C,et al.A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.Leukemia,2001,15:1176-1184.
  • 5Dallal R M, Lotze M T. The dendritic cell and human cancer vaccines[J]. Curr Opin Immunol, 2000,12(5):583-588.
  • 6Nishiyama T, Tachibana M, Horiguchi Y, et al. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide [J].Clin Cancer Res,2001,7(1):23-31.
  • 7Fong L, Brocksted D, Benike C, et al. Dendritic cell-based exnoantigen vaccination for prostate cancer immunotherapy [J]. J Immunol, 2001, 167(12): 7150-7156.
  • 8John M, Debra K, Thomas A, et al. Idiotype-pulsed dendritic cell vaccination for B cell lymphoma: clinical and immune responses in 35 patients [J]. Blood, 2002, 99(1):517-526.
  • 9Beatrice S T, Erwin S S, Thomas G B, et al. Rapid induction of tumor-specific type Ⅰ T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-load monocyte-derived dendritic cells [J]. J Exp Med, 2002,195(1):279-288.
  • 10Melero I, Duarte M, Ruiz J, et al. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas [J]. Gene Ther, 1999,6(10) :1779-1784.

共引文献9

同被引文献5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部